One Year After the Worst Day: What Fiserv’s Earnings Told Bankers
By: Paul Schaus
November 4, 2026
One year ago, Fiserv had the worst single day in its history as a public company – the stock fell 44% on October 29, 2025, after the company slashed its full-year earnings guidance – and my phone rang all morning. Not one of the callers owned the stock. They ran banks and credit unions on Fiserv cores, and every call was some version of the same question: what does this mean for us? Yesterday morning, Fiserv reported third-quarter earnings. Wall Street listened one way. I listened the way a buyer should – and that is the readout I want to give you.
Recall what actually happened last October. This was not a scandal or an outage – it was a guidance event. Fiserv cut its full-year adjusted earnings forecast from the $10.15–$10.30 range to $8.50–$8.60, told investors that growth it had promised was not coming on schedule, and the market repriced the company in a single session. The year since has been a company in visible transition. Fiserv is on its third chief executive in roughly two years: Frank Bisignano left for Washington in 2025, Mike Lyons departed in June 2026 to run Truist, and Takis Georgakopoulos – the former JPMorgan payments chief who had been co-president – took over on June 15. The other co-president, Dhivya Suryadevara, resigned less than a month later. Activist investor Jana Partners publicly pressed for a comprehensive portfolio review, arguing there is significant untapped value locked inside the company. And the divestitures have already begun: student loan servicing, managed ATM services, and unprofitable international operations are gone, while published reports say Fiserv has been shopping the Star debit network and that its debit business could draw interest from a bank-led consortium. Georgakopoulos confirmed on the second-quarter call that the debit networks are inside the review perimeter.
The second quarter itself, reported in August, showed why the review has urgency. Adjusted revenue of $4.96 billion was down 4% year over year, organic revenue fell 5%, and the company lowered full-year guidance again – to organic growth of negative 1% to flat, and adjusted earnings of $7.20–$7.40. Management attributed much of the pressure to timing, Argentina, and divestitures rather than anything structural. That may well be right. But a banker evaluating a ten-year vendor relationship does not get to average out the explanation.
Most of yesterday’s coverage focused on Clover, merchant volumes, and the stock. The numbers that matter to a bank sit in a different segment. Financial Solutions – the segment that contains the core processing, digital banking, and card services that community institutions actually buy – posted organic revenue down 8% in the second quarter, with adjusted operating income down 27%. By the company’s own account, core counts were down 3% year over year, reflecting what management itself called ongoing attrition in the banking business. Those are Fiserv’s reported figures, not an outside estimate, and they describe the install base that Premier, Precision, Cleartouch, DNA, and Signature institutions live inside.
One more second-quarter disclosure deserves a banker’s attention: the company said it would spend roughly $100 million of additional money in the second half, much of it on cybersecurity and infrastructure for Financial Solutions. Read generously, that is a vendor investing in exactly the things its bank clients need. Read skeptically, it is an admission of how much catch-up was deferred while capital went elsewhere. Both readings can be true, which is why the question belongs on your due diligence list rather than in your assumptions.
If your institution runs on a Fiserv core – or is evaluating one – these are the five questions I took into yesterday’s call as a buyer rather than an investor, and what the call answered.
This is a banking commentary, not a stock note, and here is why. In September, the federal banking agencies proposed updated third-party risk management guidance and, alongside it, a joint statement aimed squarely at core service provider relationships. The regulatory direction is unambiguous: your vendor’s financial condition, strategic direction, and operational investment are your risk, and examiners expect you to monitor them the way you would monitor a large borrower. A year ago, the market repriced Fiserv in six and a half hours. A bank cannot reprice a core relationship in six and a half hours – or six and a half months. That asymmetry is the entire reason to listen to an earnings call like a buyer: the market gets to exit; you get to manage.
So whatever you make of yesterday’s print, do three things this week. Pull the contract and reread the deconversion, data extraction, and migration clauses – including what happens to your platform if it is consolidated or your business unit is sold. Put the five questions above to your relationship manager in writing, and keep the answers in your vendor file; under the proposed guidance, that file is where your monitoring is supposed to live. And brief your board with the segment numbers, not the headlines – directors who hear “core accounts down 2%, banking revenue down 5%, attrition improving” will govern the relationship differently than directors who hear “Fiserv beat earnings.”
Fiserv is no longer a vendor in freefall, but it is not yet a vendor in recovery. The quarter showed stabilization – guidance held, attrition improving, investment visible – and the strategy is finally coherent: fewer cores, common components, a smaller portfolio. What it has not shown is proof. For institutions on Premier, Precision, or Cleartouch, the direction now points toward CoreAdvance, and CoreAdvance itself is still being built in phases; negotiate which phases you are entitled to, and on what dates, in your next contract, while Fiserv needs retention wins. For DNA institutions, the call placed DNA among Fiserv’s leading client wins, but it still sits outside the CoreAdvance consolidation – get the investment commitment in writing. For banks evaluating Fiserv, this is a buyer’s market: a vendor rebuilding its sales motion will trade price, terms, and conversion support for a reference. Our test for the next 12 to 18 months: named CoreAdvance clients live on phases beyond infrastructure consolidation, attrition improvement appearing in reported banking revenue by late 2027, and divestitures that leave the bank-facing business intact.
My final comment: a year after the worst day, the most useful thing the crash taught the industry has nothing to do with Fiserv in particular. Every critical vendor – public, private equity-owned, or cooperative – has a financial condition, a strategy under revision, and an owner with options. The banks that handled last October calmly were not the ones with the best stock forecasts; they were the ones that already knew which risks they were carrying, had the contract language to match, and could answer their boards from their own files. Yesterday’s call was the best one Fiserv’s bank clients have heard in two years – attrition peaking, guidance held, investment visible, a named, $20 billion CoreAdvance go-live. Put it in the file next to the five questions, and ask the sixth one in writing: the call promised that common componentry will end the question of how many cores Fiserv has – so which componentry, on what dates, reaches the core your institution runs?
CCG Catalyst advises banks, credit unions, and fintech companies on core evaluation, vendor selection, and contract negotiation. If your institution is approaching a core decision, reach out to our team at www.ccgcatalyst.com.
See our latest announcement: CCG Catalyst’s Paul Schaus Named a 2026 Top Consultant by Consulting Magazine
By: Paul Schaus | Founder & Managing Partner, CCG Catalyst Consulting
Disclaimer: The views expressed in this article represent the perspective of CCG Catalyst Consulting based on our direct experience advising financial institutions. This commentary is intended to stimulate industry discussion and does not constitute legal, accounting, or regulatory advice.